SEC Form 4 · accession 0001127602-17-008154
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 22, 2017
Accepted (ET)
Feb 24, 2017 · 2:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2017 | S | 300 | $87.75 | D | 378,277 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.755 | D | 378,077 | D | |
| Common Stock | Feb 22, 2017 | S | 500 | $87.76 | D | 377,577 | D | |
| Common Stock | Feb 22, 2017 | S | 720 | $87.77 | D | 376,857 | D | |
| Common Stock | Feb 22, 2017 | S | 906 | $87.78 | D | 375,951 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.795 | D | 375,751 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.80 | D | 375,551 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.805 | D | 375,451 | D | |
| Common Stock | Feb 22, 2017 | S | 452 | $87.81 | D | 374,999 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.82 | D | 374,799 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.83 | D | 374,699 | D | |
| Common Stock | Feb 22, 2017 | S | 148 | $87.84 | D | 374,551 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.85 | D | 374,451 | D | |
| Common Stock | Feb 22, 2017 | S | 734 | $87.86 | D | 373,717 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.865 | D | 373,617 | D | |
| Common Stock | Feb 22, 2017 | S | 1,000 | $87.87 | D | 372,617 | D | |
| Common Stock | Feb 22, 2017 | S | 600 | $87.88 | D | 372,017 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.895 | D | 371,917 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.90 | D | 371,717 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.91 | D | 371,517 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.92 | D | 371,317 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.93 | D | 371,117 | D | |
| Common Stock | Feb 22, 2017 | S | 300 | $87.94 | D | 370,817 | D | |
| Common Stock | Feb 22, 2017 | S | 598 | $87.95 | D | 370,219 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.96 | D | 370,119 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.97 | D | 369,919 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.